You take the pill. You have started, or are about to start, one of the weekly injections prescribed for weight. And you would like to be pregnant at some point — not this month, but not never either.
Three separate decisions are sitting inside that, and they belong to three different moments: whether your contraception is still doing its job right now, how long before trying to conceive the injection has to stop, and what happens if a pregnancy test comes back positive earlier than any of it was planned. The answers are not the same for every medicine of this kind, which is the part people get wrong. You can settle the first two this week, and the third comes down to one question, asked once, of whoever prescribes for you.
On tirzepatide, the printed instruction for someone using a contraceptive they swallow is to switch to a method that is not swallowed, or to add a barrier method, for four weeks after starting, and for four weeks after each increase. On semaglutide, no contraceptive switch is printed. Before trying to conceive, the semaglutide labeling prints a stop at least two months ahead; the tirzepatide labeling prints no equivalent lead time, so that timing is a question for the prescriber rather than something to look up. If a test is already positive, both say the same thing: stop, and tell the prescriber.
Whether your birth control still works
Whether your birth control still works depends on which of these medicines is involved and on whether the contraceptive is one you swallow. Tirzepatide's prescribing information states that it may make oral hormonal contraceptives less effective, because it slows the rate at which the stomach empties, and that the delay is largest after the first dose and gets smaller over time. Printed alongside that, in the same section, is the instruction: switch to a non-oral method, or add a barrier method, for four weeks after starting and for four weeks after each increase.
Contraceptives that are hormonal but not swallowed should not be affected: the implant, the hormonal coil, the patch, the ring and the contraceptive injection. The patient-facing entry for tirzepatide is worded more broadly and names patches, rings and injections alongside the pill, so if yours is one of those, get it confirmed rather than assume it.
The mechanism is the same on semaglutide and the printed conclusion is not. Semaglutide also slows gastric emptying, which could in principle change how a swallowed medicine is absorbed; in the pharmacology trials behind its labeling, run at a dose below the usual maintenance one, it did not change how oral medicines were absorbed, and prescribers are told to watch oral medicines taken alongside it regardless. For someone on semaglutide, then, no change of contraceptive method is instructed; what is instructed is that the oral medicines be watched.
The move that matters is naming your exact method out loud — a combined pill, the mini-pill, the implant, the coil — instead of saying you are on birth control. Which one it is decides whether anything changes at all.
Stopping before you try to conceive, and how far ahead
How far ahead you have to stop depends on the medicine again, and for one of them the answer is printed and longer than people expect. Semaglutide's labeling instructs that it be stopped at least two months before a patient plans to become pregnant, because of the potential for harm to a fetus and because semaglutide leaves the body slowly. Two months is a lead time rather than a reaction, which means the conversation has to happen before contraception stops, not after.
For tirzepatide no equivalent lead time is printed, so the timing there is a question for the prescriber. Both labels do agree on what pregnancy itself is not for: losing weight offers no benefit to a pregnant patient and may harm the fetus, and appropriate weight gain — measured from the weight someone started the pregnancy at — is what is currently recommended for every pregnant patient, including those with obesity or overweight.
The practical move is to work backwards. Decide roughly when you want to start trying, count back from it, and raise it at the appointment before that date rather than the one after. A prescriber who knows a pregnancy is planned is choosing among different options than one who does not, and one of those options is a stretch of time with no treatment at all.
If you are already pregnant, or already nursing
If a test is already positive, both labels print the same instruction: stop the medicine, and tell the prescriber that a pregnancy has been recognized. Say it the day you know, rather than saving it for the next scheduled appointment.
Both labels also print a pregnancy exposure registry, which follows what happens in pregnancies where these medicines were used, and a phone number for it. Ask to be enrolled, or call the number on the label yourself. Nothing in that phone call changes your own pregnancy; it is the part of this that helps whoever asks the same question later.
Nursing is a separate question with a better-documented answer. For semaglutide the labeling records no data on whether it reaches human milk, and directs that the benefits of breastfeeding be weighed against the mother's clinical need for the medicine and any effect on the infant. The NIH lactation database reports semaglutide as not detectable in the milk of mothers using the injected form, with no adverse effects seen in their breastfed infants. Its tirzepatide entry reports the injected form as usually undetectable at the lower doses that have been studied, states that needing tirzepatide is not in itself a reason to stop breastfeeding, and advises caution while nursing a newborn or a preterm infant, with some experts advising close watch on the infant's growth and milestones.
Two things do not wait for an appointment. Being pregnant, or possibly pregnant, is by itself on the printed list of reasons to get help right away for abdominal pain — it is not a qualifier on how bad the pain is. Sudden sharp pain, vomiting blood, a belly that is rigid or tender to the touch, and difficulty breathing are separate entries on the same list. Vomiting that leaves you unable to keep down any food or liquid is among the reasons on the same page to contact your provider rather than wait for the next visit.
Say these things, in this order
- Name your exact contraceptive method to your prescriber, not the category it belongs to.
- If it is one you swallow, ask whether what you take carries the switch instruction, and which method to use instead or alongside.
- Say that a pregnancy is planned, and roughly when, at the appointment before you stop using contraception.
- If a test is positive, tell the prescriber that day and ask to be enrolled in the pregnancy exposure registry printed on your label.
- If you are nursing, say so before the first prescription rather than after it.
The sequence that suits your particular year — treatment for a while, then a gap, then trying — belongs to the prescriber and to whoever looks after the pregnancy, and it goes better when those two are in one conversation rather than two. A physician may also conclude that the year you have in mind is not a year for treatment at all, which is worth asking about early rather than discovering after you have already stopped using contraception.
